Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija (SCM1R) Q2 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2024 earnings summary
13 Jun, 2025Executive summary
Net turnover for the first six months of 2024 reached €768.3k, up 1.0% year-over-year; profit before tax was €61.4k, down 27.6% from the same period in 2023.
Bull semen sales accounted for 67.9% of net turnover, with milk laboratory and data services contributing 20.5%.
No major events or significant risks impacted the financial position during the reporting period.
A new medium-duty truck was acquired via a five-year financial lease.
Financial highlights
Net sales: €768,297 (2024) vs €760,366 (2023); profit after tax: €61,359 (2024) vs €84,719 (2023).
Earnings per share: €0.145 (2024) vs €0.201 (2023).
Cash at period end: €183,789, up from €154,235 at 2023 year-end.
Dividends paid in 2024 totaled €21,122.
Outlook and guidance
Focus remains on expanding product and service volumes by increasing operational efficiency.
Latest events from Siguldas Ciltslietu Un Maksligas Apseklosanas Stacija
- Net sales, profit, and EPS rose year-over-year, with improved equity and cash flow.SCM1R
Q3 202520 Nov 2025 - Net turnover grew 24.5% year-over-year, but profit before tax fell 6% to €57.7k.SCM1R
Q2 202521 Aug 2025 - Net sales rose 6% but net profit and EPS declined for the nine months of 2024.SCM1R
Q3 202413 Jun 2025 - 2024 net profit rose 23.5% to €80.8k, driven by genetics sales growth and stable operations.SCM1R
Q4 20249 Jun 2025 - Net sales up 24% and net profit increased, but operating cash flow turned negative.SCM1R
Q1 20256 Jun 2025